Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director
-
Stock Symbol
-
SYRE on Nasdaq
There are no Buy or Sell transactions made by Fairmount Funds Management LLC since 27 Dec 2024
Holdings reported by Fairmount Funds Management LLC for Spyre Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Stock Option (Right to Buy) |
25K |
|
|
29 May 2025 |
By Peter Harwin |
Common Stock |
|
| Stock Option (Right to Buy) |
25K |
|
|
29 May 2025 |
By Tomas Kiselak |
Common Stock |
|
Transactions reported by Fairmount Funds Management LLC for Spyre Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.